Treatment of human immunodeficiency virus infections.
作者信息
Hirsch M S, Kaplan J C
出版信息
Antimicrob Agents Chemother. 1987 Jun;31(6):839-43. doi: 10.1128/AAC.31.6.839.
Abstract
摘要
相似文献
1
Treatment of human immunodeficiency virus infections.人类免疫缺陷病毒感染的治疗。
Antimicrob Agents Chemother. 1987 Jun;31(6):839-43. doi: 10.1128/AAC.31.6.839.
2
Progress in the development of antiviral therapy for HTLV-III-associated diseases.
Important Adv Oncol. 1987:293-311.
3
Zidovudine treatment for AIDS.齐多夫定治疗艾滋病。
Nurs Times. 1987;83(39):64-5.
4
Antiviral therapy.抗病毒治疗。
Sci Am. 1987 Apr;256(4):76-85. doi: 10.1038/scientificamerican0487-76.
5
Progress in antiviral drug and vaccine development assessed at international AIDS conference.在国际艾滋病会议上评估的抗病毒药物和疫苗研发进展。
Clin Pharm. 1987 Aug;6(8):592,595-6.
6
[Chemotherapy and immunoprophylaxis of HIV infection].
Schweiz Rundsch Med Prax. 1986 Nov 25;75(48):1471-5.
7
Therapy of human immunodeficiency virus infections.
Clin Lab Med. 1987 Dec;7(4):793-813.
8
Azidothymidine (AZT).
Conn Med. 1987 Jul;51(7):453-4.
9
Antiviral drugs for AIDS. Current status and future prospects.
Drugs. 1986 Jun;31(6):463-6. doi: 10.2165/00003495-198631060-00001.
10
Anti-AIDS agents show varying early results in vitro and in vivo.抗艾滋病药物在体外和体内显示出不同的早期效果。
JAMA. 1985 Nov 8;254(18):2521, 2527, 2529. doi: 10.1001/jama.254.18.2521.
引用本文的文献
1
Antiviral Potential of Azathioprine and Its Derivative 6- Mercaptopurine: A Narrative Literature Review.硫唑嘌呤及其衍生物6-巯基嘌呤的抗病毒潜力：一篇叙述性文献综述
Pharmaceuticals (Basel). 2024 Jan 30;17(2):174. doi: 10.3390/ph17020174.
2
Pathogenesis of human immunodeficiency virus infection and prospects for control.人类免疫缺陷病毒感染的发病机制与控制前景。
Yale J Biol Med. 1987 Nov-Dec;60(6):589-600.
3
Inhibition (in vitro) of replication and of the cytopathic effect of human immunodeficiency virus by an extract of the culture medium of Lentinus edodes mycelia.
Med Microbiol Immunol. 1988;177(5):235-44. doi: 10.1007/BF00189409.
4
The synthesis of branched-chain 3'-C-cyanomethyl-2',3'-dideoxy sugar nucleosides of adenine as potential inhibitors of the human immunodeficiency virus.作为人类免疫缺陷病毒潜在抑制剂的腺嘌呤支链3'-C-氰甲基-2',3'-二脱氧糖核苷的合成。
Nucleic Acids Res. 1989 Oct 11;17(19):7663-70. doi: 10.1093/nar/17.19.7663.
5
Approaches to antiviral drug development.抗病毒药物研发方法。
Yale J Biol Med. 1989 Mar-Apr;62(2):215-25.
6
Combinations of 3'-azido-3'-deoxythymidine (zidovudine) and phosphonoformate (foscarnet) against human immunodeficiency virus type 1 and cytomegalovirus replication in vitro.3'-叠氮-3'-脱氧胸苷（齐多夫定）与膦甲酸盐（膦甲酸）联合用于抗1型人类免疫缺陷病毒及体外巨细胞病毒复制的研究
Antimicrob Agents Chemother. 1989 May;33(5):663-9. doi: 10.1128/AAC.33.5.663.
7
Feline immunodeficiency virus, a model for reverse transcriptase-targeted chemotherapy for acquired immune deficiency syndrome.猫免疫缺陷病毒，一种用于获得性免疫缺陷综合征的逆转录酶靶向化疗的模型。
Antimicrob Agents Chemother. 1989 Jun;33(6):915-9. doi: 10.1128/AAC.33.6.915.
8
Combinations of isoprinosine and 3'-azido-3'-deoxythymidine in lymphocytes infected with human immunodeficiency virus type 1.在感染1型人类免疫缺陷病毒的淋巴细胞中异丙肌苷与3'-叠氮-3'-脱氧胸苷的联合应用
Antimicrob Agents Chemother. 1988 Dec;32(12):1784-7. doi: 10.1128/AAC.32.12.1784.
9
In vitro and in vivo effects of ribavirin on human respiratory epithelium.利巴韦林对人呼吸道上皮的体外和体内作用。
Thorax. 1990 Feb;45(2):100-4. doi: 10.1136/thx.45.2.100.
10
In vitro inhibition of the infectivity and replication of human immunodeficiency virus type 1 by combination of antiretroviral 2',3'-dideoxynucleosides and virus-binding inhibitors.抗逆转录病毒2',3'-双脱氧核苷与病毒结合抑制剂联合对人免疫缺陷病毒1型感染性和复制的体外抑制作用
Antimicrob Agents Chemother. 1990 Jan;34(1):82-8. doi: 10.1128/AAC.34.1.82.
本文引用的文献
1
Ribavirin suppresses replication of lymphadenopathy-associated virus in cultures of human adult T lymphocytes.利巴韦林可抑制人成年T淋巴细胞培养物中与淋巴结病相关病毒的复制。
Lancet. 1984 Dec 15;2(8416):1367-9. doi: 10.1016/s0140-6736(84)92060-9.
2
In vitro suppression of HTLV-III/LAV infectivity by a combination of acyclovir and suramin.
J Infect Dis. 1986 Dec;154(6):1027-30. doi: 10.1093/infdis/154.6.1027.
3
Prospects for the prevention and therapy of infections with the human immunodeficiency virus.人类免疫缺陷病毒感染的预防与治疗前景
Rev Infect Dis. 1986 Nov-Dec;8(6):991-1000. doi: 10.1093/clinids/8.6.991.
4
Synergistic inhibition of human immunodeficiency virus in vitro by azidothymidine and recombinant alpha A interferon.叠氮胸苷与重组αA干扰素在体外对人类免疫缺陷病毒的协同抑制作用。
Antimicrob Agents Chemother. 1987 Feb;31(2):168-72. doi: 10.1128/AAC.31.2.168.
5
Octapeptides deduced from the neuropeptide receptor-like pattern of antigen T4 in brain potently inhibit human immunodeficiency virus receptor binding and T-cell infectivity.从脑中抗原T4的神经肽受体样模式推导出来的八肽能有效抑制人类免疫缺陷病毒受体结合及T细胞感染性。
Proc Natl Acad Sci U S A. 1986 Dec;83(23):9254-8. doi: 10.1073/pnas.83.23.9254.
6
Both 2',3'-dideoxythymidine and its 2',3'-unsaturated derivative (2',3'-dideoxythymidinene) are potent and selective inhibitors of human immunodeficiency virus replication in vitro.2',3'-双脱氧胸苷及其2',3'-不饱和衍生物（2',3'-双脱氧胸苷烯）在体外都是人类免疫缺陷病毒复制的强效和选择性抑制剂。
Biochem Biophys Res Commun. 1987 Jan 15;142(1):128-34. doi: 10.1016/0006-291x(87)90460-8.
7
Potent and selective anti-HTLV-III/LAV activity of 2',3'-dideoxycytidinene, the 2',3'-unsaturated derivative of 2',3'-dideoxycytidine.
Biochem Biophys Res Commun. 1986 Oct 30;140(2):735-42. doi: 10.1016/0006-291x(86)90793-x.
8
Synergistic inhibition of human T-cell lymphotropic virus type III replication in vitro by phosphonoformate and recombinant alpha-A interferon.膦甲酸盐与重组α-A干扰素在体外对人嗜T细胞病毒III型复制的协同抑制作用
Antimicrob Agents Chemother. 1986 Jul;30(1):189-91. doi: 10.1128/AAC.30.1.189.
9
Recombinant human interferon gamma suppresses HTLV-III replication in vitro.重组人干扰素γ在体外可抑制人嗜T淋巴细胞病毒III型（HTLV-III）的复制。
Int J Cancer. 1986 Sep 15;38(3):433-6. doi: 10.1002/ijc.2910380320.
10
Initial studies on the cellular pharmacology of 2',3-dideoxycytidine, an inhibitor of HTLV-III infectivity.对2',3 - 双脱氧胞苷（一种HTLV - III感染性抑制剂）的细胞药理学的初步研究。
Biochem Pharmacol. 1986 Jul 1;35(13):2065-8. doi: 10.1016/0006-2952(86)90571-x.
Zotero 插件